Topics include the microbiome, oncology, 3D bioprinting, and
CRISPR/CAS9 gene editing
WILMINGTON, Mass.--(BUSINESS WIRE)--Aug. 29, 2017--
Charles River Laboratories International, Inc. is proud to host the Inaugural
Charles River World Congress on Animal Models in Drug Discovery &
Development. Ranging from academia to the commercial sector, the World
Congress on Animal Models speakers are each regarded as leaders in
their respective fields.
At the Boston-based conference, being held on September 26-27, 2017,
attendees will have access to keynotes and breakout sessions focused on
the driving trends in reverse translational medicine.
The 25 keynote and breakout session speakers will present topics
including: traditional and non-traditional animal models, novel in
vitro and ex vivo approaches to disease modeling, and the
application of technologies such as CRISPR/Cas9 gene editing, 3D
bioprinting, the exploitation of the microbiome, and co-opting the
immune system in the treatment of disease.
Jay Berzofsky, MD, PhD, Center for Cancer Research, National
Cancer Institute, will discuss the translation of cancer vaccines from
mouse models to clinical trials.
David Sabatini, MD, PhD, Whitehead Institute for Biomedical
Research and Howard Hughes Medical Institute, will discuss genetic
screens to study cancer biology. This year, Sabatini won the Lurie
Prize in Biomedical Sciences from the Foundation for the National
Institutes of Health.
Elazer Edelman, MD, PhD, Massachusetts Institute of Technology,
Brigham and Women's Hospital and CBSET, will provide a historical
perspective on reverse translational medicine. Edelman is a fellow of
the National Academies of Medicine, of Engineering and of Inventors,
and the American Academy of Arts and Sciences.
Jake Lusis, PhD, University of California, Los Angeles, will
present on the complex interactions between metabolic and
cardiovascular disease. Lusis was the 2015 Recipient of the Anitschkow
Prize from the European Atherosclerosis Society.
The World Congress on Animal Models is a two-day scientific
program presented by Charles River, in partnership with BioPharm
America™. Attendees also receive full access to BioPharm America™ and
Week Boston events. To learn more and register, visit breakthroughs.criver.com
and follow #CRLworldcon on social media.
“We are proud to welcome a distinguished group of speakers to Boston
for the World Congress on Animal Models. With leaders from
industry, the academic community, leading research hospitals and
government agencies, our conference will provide a robust perspective
on the state of translational medicine.” –Joseph Murphy, PhD, Program
Committee Member for the World Congress on Animal Models
“The field of reverse translational medicine is important now more
than ever. There is a critical need for continued, innovative drug
discovery, and the bedside-to-bench approach provides an opportunity
to repurpose valuable research. Bringing these leaders together will
invigorate the conversation, and set the tone for years to come.”
–Anjli Venkateswaran, PhD, Program Committee Member for the World
Congress on Animal Models
About Charles River
Charles River provides essential
products and services to help pharmaceutical and biotechnology
companies, government agencies and leading academic institutions around
the globe accelerate their research and drug development efforts. Our
dedicated employees are focused on providing clients with exactly what
they need to improve and expedite the discovery, early-stage development
and safe manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170829005192/en/
Source: Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc.
Corporate Vice President, Public Relations